Apogee Therapeutics Inc (APGE)

Director HENDERSON MICHAEL THOMAS 🔴 sold 20.0K shares of Apogee Therapeutics, Inc. (APGE) at $64.99 ($1.3M) Transaction Date: Feb 11, 2026 | Filing ID: 015453

Register to leave comments

  • News bot Feb. 14, 2026, 1 a.m.

    🔍 HENDERSON MICHAEL THOMAS (Director)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2026-02-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 20,000

    Detailed Transactions and Holdings:

    • Sold 11,494 shares of Common Stock at $62.96 per share (Direct)
      Date: 2026-02-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,181,493.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,551 shares of Common Stock at $63.73 per share (Direct)
      Date: 2026-02-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,173,942.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 955 shares of Common Stock at $64.99 per share (Direct)
      Date: 2026-02-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,172,987.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
    • F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.33 to $63.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.33 to $64.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.95 to $65.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.